Skip to main navigation
Skip to search
Skip to main content
Northern Arizona University Home
Home
Profiles
Departments and Centers
Scholarly Works
Activities
Grants
Datasets
Prizes
Search by expertise, name or affiliation
Current pharmacotherapies for obesity: A practical perspective
Angela Golden
Nursing, College of
Research output
:
Contribution to journal
›
Article
›
peer-review
16
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Current pharmacotherapies for obesity: A practical perspective'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Obesity
100%
Obesity Pharmacotherapy
100%
Pharmacotherapy
100%
United States
50%
Comorbidity
50%
Physical Activity
25%
Diabetes
25%
Behavior Change
25%
Weight Loss
25%
Lifestyle Modification
25%
Literature Search
25%
Implications for Practice
25%
Patient Preference
25%
Narrative Review
25%
Treatment Choice
25%
Lorcaserin
25%
Common Obesity
25%
Obesity-related Complications
25%
Preference-based
25%
Route of Administration
25%
Prescribing Information
25%
Alcohol Ban
25%
Liraglutide 3.0 Mg
25%
Caloric Restriction
25%
Obesity Management
25%
Orlistat
25%
Phentermine
25%
Safety Profile
25%
Patient Preparation
25%
Short-term Use
25%
Individual Preferences
25%
Medicine and Dentistry
Drug Therapy
100%
Diabetes
16%
Physical Activity
16%
Obesity
16%
Health Care Cost
16%
Phentermine
16%
Liraglutide
16%
Behavioral Change
16%
Lorcaserin
16%
Obesity Management
16%
Orlistat
16%
Drug Administration Route
16%
Contraindication
16%
Lifestyle Modification
16%
Caloric Restriction
16%
Nursing and Health Professions
Drug Therapy
100%
Comorbidity
33%
Obesity
16%
Lifestyle Modification
16%
Tetrahydrolipstatin
16%
Phentermine
16%
Liraglutide
16%
Contraindication
16%
Lorcaserin
16%
Drug Administration Route
16%
Obesity Management
16%
Caloric Restriction
16%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacotherapy
100%
Comorbidity
33%
Obesity
16%
Ethanol
16%
Liraglutide
16%
Phentermine
16%
Lorcaserin
16%
Tetrahydrolipstatin
16%